Pharma Journalist -

SMi Reports: Ben Cox from Team Consulting Ltd is interviewed for the Injectable Drug Delivery conference In light of COVID-19, SMi Group’s 3rd annual Injectable Drug Delivery has…
Read More...

Vaccitech Limited and the University of Oxford announce initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in…
Read More...

ProBioGen AG announced that Immunogenesis, Inc., a spin-off of the MD Anderson Cancer Center, University of Texas, has signed a Service Agreement for Cell Line Development, Process…
Read More...

AbbVie announced the VIALE-A (M15-656) trial of VENCLEXTA (venetoclax) in combination with azacitidine versus azacitidine in combination with placebo met its dual primary endpoints of…
Read More...

Hoth Therapeutics, Inc. announced that it has reached an agreement with Voltron Therapeutics, Inc. (Voltron) to form a joint venture entity, to be named HaloVax, to commence preclinical…
Read More...

In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc. and SmartPharm Therapeutics Inc. (SmartPharm) announced a research and development…
Read More...

Flexipharm Austrading, the UK specialty pharmaceutical company focused on supplying the NHS with Better, Critical Care Medicines, announced an important improvement to the 'Summary of…
Read More...

Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, announced a research collaboration and license agreement for Curadev’s Stimulator of Interferon Genes (STING)…
Read More...

Takeda Pharmaceutical Company Limited has announced that the gut-selective biologic Entyvio (vedolizumab) was approved by China’s National Medical Products Administration (NMPA). The…
Read More...

Genentech, a member of the Roche Group announced that the Phase III VIALE-A study met its dual primary endpoints of overall survival and composite complete remission rate (CR + CRi).…
Read More...